BBIO

BRIDGEBIO PHARMA INC

Healthcare | Large Cap

-$0.64

EPS Forecast

$306.5

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31

Proximilar's AI forecasts

EPS Forecast:

-$0.64

Revenue Forecast:

$306.5

EPS Surprise Forecast:

-$0.043

Revenue Surprise Forecast:

$10

Post-release price volatility - High

Post-release Overnight Move:

±8.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

40%

Probability of beating revenue consensus:

73%

Probability of beating both EPS & revs consensus:

35%

Probability of missing both EPS & revs consensus:

21%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

0.64

Earnings volatility

EPS standard deviation:

$0.27

Revenue standard deviation:

$34

As % of share price:

0.42% HIGH

As % of market cap:

0.27% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.27

Revenue 95th %ile:

$354

EPS 75th %ile:

-$0.54

Revenue 75th %ile:

$319

EPS 25th %ile:

-$0.71

Revenue 25th %ile:

$296

EPS 5th %ile:

-$0.92

Revenue 5th %ile:

$268

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

43% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

66% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$11

Bid-ask per Share:

$0.07